3|0|Public
50|$|<b>Pipamazine</b> (INN; {{trade names}} Mornidine, Mometine, Nausidol) {{is a drug}} of the {{phenothiazine}} class formerly used as an antiemetic. It is chemically related to chlorpromazine, but has negligible antipsychotic activity and produces few extrapyramidal side effects.|$|E
50|$|In {{his book}} The Creation of Psychopharmacology, Irish {{psychiatrist}} David Healy {{states that the}} failure of <b>pipamazine</b> to perform as a neuroleptic and its negative side effect profile helped Searle lose interest in the antipsychotic sector, {{and contributed to the}} company's refusal to market haloperidol in the United States.|$|E
50|$|<b>Pipamazine</b> was {{introduced}} to the U.S. market in 1959 by G. D. Searle & Company. It was advertised for morning sickness and postoperative nausea and vomiting, and was claimed to reduce the need for postoperative analgesia.It was eventually withdrawn from the U.S. market in 1969, after reports of hepatotoxicity (liver injury).|$|E

